Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 24, Issue 6

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 24, Issue 6 (2015)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 24, Issue 6 (2015)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Volume 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Valbenazine granted breakthrough drug status for treating tardive dyskinesia

Thomas Müller MD

Pages: 737-742

Published online: 25 Mar 2015

AbstractforValbenazine granted breakthrough drug status for treating tardive dyskinesia | Full Text | References | PDF (230.9 KB)

7610 Views
36 CrossRef citations
0Altmetric

Free Access

Review

Investigational agents for treatment of traumatic brain injury

Ye Xiong MD PhD, Yanlu Zhang MD, Asim Mahmood MD & Michael Chopp PhD

Pages: 743-760

Published online: 01 Mar 2015

AbstractforInvestigational agents for treatment of traumatic brain injury | Full Text | References | PDF (504 KB)

643 Views
61 CrossRef citations
0Altmetric

Early investigational TNF receptor antagonists for the treatment of ulcerative colitis

Ian C Lawrance (Professor)

Pages: 761-768

Published online: 26 Feb 2015

AbstractforEarly investigational TNF receptor antagonists for the treatment of ulcerative colitis | Full Text | References | PDF (229.1 KB)

391 Views
5 CrossRef citations
0Altmetric

Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials

Nelson Valentin BS, Andres Acosta MD PhD & Michael Camilleri MD

Pages: 769-779

Published online: 14 May 2015

AbstractforEarly investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials | Full Text | References | PDF (242.9 KB)

324 Views
22 CrossRef citations
0Altmetric

Phase II clinical trials on investigational drugs for the treatment of pancreatic cancers

Edward J Kim MD PhD, Thomas J Semrad MD MAS & Richard J Bold MD

Pages: 781-794

Published online: 25 Mar 2015

AbstractforPhase II clinical trials on investigational drugs for the treatment of pancreatic cancers | Full Text | References | PDF (316.4 KB)

266 Views
2 CrossRef citations
0Altmetric

Promising therapies for the treatment of chronic lymphocytic leukemia

Fortunato Morabito, Anna Grazia Recchia, Ernesto Vigna, Laura De Stefano, Sabrina Bossio, Lucio Morabito, Mariavaleria Pellicanò, Angela Palummo, Francesca Storino, Nadia Caruso & Massimo Gentile

Pages: 795-807

Published online: 01 Mar 2015

AbstractforPromising therapies for the treatment of chronic lymphocytic leukemia | Full Text | References | PDF (398.5 KB)

677 Views
4 CrossRef citations
0Altmetric

Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer

Matteo Santoni MD, Francesco Massari, Marzia Del Re, Chiara Ciccarese, Francesco Piva, Giovanni Principato, Rodolfo Montironi, Daniele Santini, Romano Danesi, Giampaolo Tortora & Stefano Cascinu

Pages: 809-824

Published online: 07 Mar 2015

AbstractforInvestigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer | Full Text | References | PDF (493.8 KB)

474 Views
36 CrossRef citations
0Altmetric

Drug Evaluation

Ranolazine for the treatment of atrial fibrillation

Gian Marco Rosa MD PhD, Ulrico Dorighi MD, Simone Ferrero MD PhD, Michele Brunacci MD, Giovanni Bertero MD & Claudio Brunelli MD

Pages: 825-836

Published online: 15 Apr 2015

AbstractforRanolazine for the treatment of atrial fibrillation | Full Text | References | PDF (438.2 KB)

403 Views
8 CrossRef citations
0Altmetric

Cebranopadol: a first-in-class potent analgesic agent with agonistic activity at nociceptin/orphanin FQ and opioid receptors

Kinga Sałat, Anna Jakubowska & Katarzyna Kulig

Pages: 837-844

Published online: 12 Apr 2015

AbstractforCebranopadol: a first-in-class potent analgesic agent with agonistic activity at nociceptin/orphanin FQ and opioid receptors | Full Text | References | PDF (467.5 KB)

461 Views
18 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.24, Iss.6, 2015)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?